Product Reports Resources Pricing Login Book a demo

PathAI

Biotech & Life Sciences · Boston, United States · Founded 2016

AI-powered pathology platform optimizing diagnostic accuracy and research MoreLess

PathAI is dedicated to improving patient outcomes through its AI-powered pathology platform. The company focuses on enhancing the accuracy of diagnoses and the efficacy of treatments for diseases such as cancer by leveraging advanced machine learning techniques. PathAI serves healthcare providers, research institutions, and pharmaceutical companies, operating primarily in the medical and healthcare markets. The business model revolves around providing AI-driven diagnostic tools and services, generating revenue through partnerships, licensing, and service fees. The company is headquartered in Fenway and boasts a diverse team committed to solving complex problems and making a significant impact. PathAI has also been recognized as one of BBJ's Best Places to Work.

Keywords: AI, pathology, diagnosis, treatment, cancer, machine learning, healthcare, medical, patient outcomes, Fenway.

Valuation $500M–1B
Revenue $100–500M
Headcount 100–500
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for PathAI and the history behind them.

Talent graph

PathAI's talent

Book a demo to see the people
Team profiled 30 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

16 investors on PathAI's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Fairhaven Capital Partners
Refactor Capital
8VC
Pillar VC
Series A 6 investors entered at this stage
General Catalyst
KdT Ventures
General Atlantic
LabCorp
Bristol-Myers Squibb
Merck Global Health Innovation Fund
Series B+ 6 investors entered at this stage
Kaiser Permanente
D1 Capital Partners
Polaris Partners
Biospring Partners
Tiger Global
Adage Ventures

Global footprint

Where PathAI has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States91.9%
🇨🇦 Canada3.3%
🇧🇷 Brazil0.9%
🇵🇰 Pakistan0.9%
🇺🇦 Ukraine0.5%
Top 5 of 9 shown

Market sentiment

What the market is saying about PathAI

An AI-synthesized read of the highest-engagement posts about PathAI on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PathAI on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.